Bluejay Diagnostics, Inc. (BJDX )

Currency in USD Disclaimer
$4.5 -$0.73 (-13.96%)
Closed 06/09/2026
$4.38
$5.59
$1.62
$16.68

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol BJDX
  • Company Bluejay Diagnostics, Inc.
  • Price $4.5
  • Changes Percentage -13.96
  • Change -0.73
  • Day Low $4.38
  • Day High $5.59
  • Year High $16.68
  • Year Low $1.62
  • Market Cap $2,045,470
  • Price Avg 50 EMA (D) $1.95
  • Price Avg 200 EMA (D) $4.2
  • Exchange NASDAQ
  • Volume 1,088,689
  • Average Volume 1,241,098
  • Open $5.59
  • Previous Close $5.23
  • EPS -3.74
  • PE -1.21
  • Earnings Announcement 2026-08-19 12:00:00
  • Shares Outstanding $453,541

Company brief: BLUEJAY DIAGNOSTICS, INC. (BJDX )

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

BJDX Corporation News

Income Statement